Factors that Influence Intraocular Pressure Target in a Sample of Iraqi Patients Using Antiglaucoma Medications: A Cross-Sectional Study
DOI:
https://doi.org/10.54133/ajms.v7i2.1283Keywords:
Adherence, Glaucoma, Iraqi patients, Intraocular pressure, Treatment targetAbstract
Background: Anti-glaucoma eye drops are mainly used to lower intraocular pressure (IOP) and manage glaucoma. Many studies found that achievement of the IOP target is poor. Objective: This study aimed to assess the achievement of the IOP target and factors affecting it among a sample of Iraqi patients with glaucoma. Methods: A single-center, cross-sectional study was conducted on patients with glaucoma from December 2023 to April 2024 at Ibn Al-Haytham Hospital, Baghdad, Iraq. All patients who received medical therapy for at least one month were eligible to participate in this study. Intraocular pressure values at the time of initial diagnosis and at the time of enrolment in the study were documented for all included patients. Medication adherence was measured by the Arabic version of the Morisky medication adherence scale-4. Eyedrop administration technique was assessed through direct observation by the researcher using a newly developed and validated checklist. Results: Most participants in the current study were males with primary education. The average disease duration was 14 months. The target IOP was achieved among 36% of participants. The adherence to eye drops was good in 55% of participants. Only 9% of participants administered eye drops with a good technique. Achievement of the IOP target was significantly influenced by good adherence and technique for administration of eye drops (p<0.05). Conclusions: IOP-target achievement is poor among Iraqi patients. Adherence to and administration technique of eye drops are significant factors that could affect IOP-target achievement.
Downloads
References
Allison K, Patel D, Alabi O. Epidemiology of glaucoma: The past, present, and predictions for the future. Cureus. 2020;12(11):e11686. doi: 10.7759/cureus.11686.
Torabi R, Harris A, Siesky B, Zukerman R, Oddone F, Mathew S, et al. Prevalence rates and risk factors for primary open angle glaucoma in the Middle East. J Ophthalmic Vis Res. 2021;16(4):644-656. doi: 10.18502/jovr.v16i4.9755.
Cook C, Foster P. Epidemiology of glaucoma: what's new? Can J Ophthalmol. 2012;47(3):223-226. doi: 10.1016/j.jcjo.2012.02.003.
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901-1911. doi: 10.1001/jama.2014.3192.
Harasymowycz P, Birt C, Gooi P, Heckler L, Hutnik C, Jinapriya D, et al. Medicalmanagement of glaucoma in the 21st century from a Canadian perspective. J Ophthalmol. 2016;2016:6509809. doi: 10.1155/2016/6509809.
Sihota R, Angmo D, Ramaswamy D, Dada T. Simplifying "target" intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma. Indian J Ophthalmol. 2018;66(4):495-505. doi: 10.4103/ijo.IJO_1130_17.
Nordmann JP, Auzanneau N, Ricard S, Berdeaux G. Vision related quality of life and topical glaucoma treatment side effects. Health Qual Life Outcomes. 2003;1:75. doi: 10.1186/1477-7525-1-75.
Saif AT, Saif P. Achieving target IOP. J Glaucoma-Cataract. 2017;12(1):60-69.
Atey TM, Shibeshi W, T Giorgis A, Asgedom SW. The impact of adherence and instillation proficiency of topical glaucoma medications on intraocular pressure. J Ophthalmol. 2017;2017:1683430. doi: 10.1155/2017/1683430.
Warjri GB, Sidhu T, Kishan A, Behera AK, Shakrawal J, Selvan H, et al. Achieving low target intraocular pressures in severe glaucoma. Eur J Ophthalmol. 2021;31(6):3068-3073. doi: 10.1177/1120672120979903.
Sadiq M, Mahsood YJ, Ahmad W, Khan MA, Akhtar F. Changes in the treatment plans of glaucoma patients in a real-world situation. Khyber Med Univ J. 2022;14(1):21-26.doi: 10.35845/kmuj.2022.21634.
Clement CI, Bhartiya S, Shaarawy T. New perspectives on target intraocular pressure. Survey Ophthalmol. 2014;59(6):615-626. doi: 10.1016/j.survophthal.2014.04.001.
Zaharia AC, Dumitrescu OM, Radu M, Rogoz RE. Adherence to therapy in glaucoma treatment-A review. J Persian Med. 2022;12(4):514. doi: 10.3390/jpm12040514.
Sleath B, Blalock S, Covert D, Stone JL, Skinner AC, Muir K, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118(12):2398-2402. doi: 10.1016/j.ophtha.2011.05.013.
Memon MA, Ting H, Cheah JH, Thurasamy R, Chuah F, Cham TH. Sample size for survey research: review and recommendations. J Appl Struct Equ Modeling. 2020;4(2):1-20. doi: 10.47263/JASEM.4(2)01.
DiPiro JT, DiPiro CV, Schwinghammer TL, Wells BG. Pharmacotherapy Handbook. McGraw-hill; 2015.
Awwad O, AlMuhaissen S, Al-Nashwan A, AbuRuz S. Translation and validation of the Arabic version of the Morisky, Green and Levine (MGL) adherence scale. PLoS One. 2022;17(10):e0275778. doi: 10.1371/journal.pone.0275778.
Naito T, Namiguchi K, Yoshikawa K, Miyamoto K, Mizoue S, Kawashima Y, et al. Factors affecting eye drop instillation in glaucoma patients with visual field defect. PLoS One. 2017;12(10):e0185874. doi: 10.1371/journal.pone.0185874.
Mehuys E, Delaey C, Christiaens T, Van Bortel L, Van Tongelen I, Remon JP, et al. Eye drop technique and patient-reported problems in a real-world population of eye drop users. Eye (Lond). 2020;34(8):1392-1398. doi: 10.1038/s41433-019-0665-y.
Davis SA, Sleath B, Carpenter DM, Blalock SJ, Muir KW, Budenz DL. Drop instillation and glaucoma. Curr Opin Ophthalmol. 2018;29(2):171-177. doi: 10.1097/ICU.0000000000000451.
Carey K, Hendricks BC. Eye disorders. In: Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, (Eds.), Applied Therapeutics: The Clinical Use of Drugs. Lippincott Williams & Wilkin, Philadelphia; 2013.
Feleke BT, Wale MZ, Yirsaw MT. Knowledge, attitude and preventive practice towards COVID-19 and associated factors among outpatient service visitors at Debre Markos compressive specialized hospital, north-west Ethiopia, 2020. PLoS One. 2021;16(7):e0251708. doi: 10.1371/journal.pone.0251708.
Sadiq DR, Mikhael EM. The achievement of IOP target among a sample of Iraqi patients with glaucoma: A Retrospective study. Clin Ophthalmol. 2024;18:2107-2112. doi: 10.2147/OPTH.S478850.
Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140(4):598-606. doi: 10.1016/j.ajo.2005.04.051.
Newman-Casey PA, Robin AL, Blachley T, Farris K, Heisler M, Resnicow K, Lee PP. The most common barriers to glaucoma medication adherence: A cross-sectional survey. Ophthalmology. 2015;122(7):1308-1316. doi: 10.1016/j.ophtha.2015.03.026.
Mowatt L, Nelson-Imoru J, Gordon-Strachan G. Glaucoma medication compliance issues in a Jamaican hospital eye clinic. West Indian Med J. 2011;60(5):541-547. PMID: 22519230.
Barakat NA, AlGhanem R, Abdulrazeq B, AlKhatib HS, AlRyalat SA, Muhsen S, et al. Improving medication adherence in glaucoma patients: a randomized controlled interventional study. J Pharm Health Services Res. 2024;15(2):rmae003. doi: 10.1093/jphsr/rmae003.
Khandekar R, Shama Mel S, Mohammed AJ. Noncompliance with medical treatment among glaucoma patients in Oman--a cross-sectional descriptive study. Ophthalmic Epidemiol. 2005;12(5):303-309. doi: 10.1080/09286580500224602.
Abu Hussein NB, Eissa IM, Abdel-Kader AA. Analysis of factors affecting patients' compliance to topical antiglaucoma medications in Egypt as a developing country model. J Ophthalmol. 2015;2015:234157. doi: 10.1155/2015/234157.
Kholdebarin R, Campbell RJ, Jin YP, Buys YM. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol. 2008;43(4):454-461. doi: 10.1139/i08-076.
Mikhael EM. Assessing the adherence to insulin therapy and the effect of injection pain on insulin adherence among type 2 diabetes mellitus patients. J Pharm Negative Results. 2020;11(1):65-58. doioi: 10.4103/jpnr.JPNR_8_19.
Flach AJ. The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies. Trans Am Ophthalmol Soc. 2008;106:138-145;145-148. PMID: 19277229.
AL-Kozaay MJ. The poverty in Iraq between the reality and the poor planning. Alustath J Hum Soc Sci. 2016;217(2):9-24.doi:10.36473/ujhss.v217i2.564.
Shabila NP, Al-Tawil NG, Al-Hadithi TS, Sondorp E, Vaughan K. Iraqi primary care system in Kurdistan region: providers' perspectives on problems and opportunities for improvement. BMC Int Health Hum Rights. 2012;12:21. doi: 10.1186/1472-698X-12-21.
Anwer IY, Yawuz MJ and Al-Jumaili AA. In-depth assessment of Iraqi physicians' adherence to treatment guidelines for different diseases: a qualitative study. F1000Research. 2023;12:350. doi: 10.12688/f1000research.128233.1.
Gomes BF, Paredes AF, Madeira N, Moraes HV, Santhiago MR. Assessment of eye drop instillation technique in glaucoma patients. Arq Bras Oftalmol. 2017;80(4):238-241. doi: 10.5935/0004-2749.20170058.
YuEL, Ramaya H, Din HK, Haris N, Zakaria SS, Mohan S. Improving eye drop administration technique among glaucoma patients in the outpatient pharmacy department at Tuanku Ampuan Najihah hospital. Q Bulletin. 2022;1(31):20-35.
Bergen NK, Labonté R. Everything is perfect, and we have no problems: Detecting and limiting social desirability bias in qualitative research. Qual Health Res. 2020;30(5):783-792. doi: 10.1177/1049732319889354.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Published by Al-Rafidain University College. This is an open access journal issued under the CC BY-NC-SA 4.0 license (https://creativecommons.org/licenses/by-nc-sa/4.0/).